Axios Re:Cap

Joe Biden has a very different prescription for America's economy than does President Trump. Not just in terms of how to tax and spend, but also in how to approach trading partners like China. Dan digs into Biden's policies and philosophies with former presidential candidate and current Biden campaign surrogate Pete Buttigieg.

Fracking for natural gas has become a flashpoint in the election's final week, particularly in Pennsylvania where both President Trump and former Vice President Biden made stops yesterday. But much of the political rhetoric has ignored that the industry has gone from boom to bust, beset by layoffs, bankruptcies and fire-sale mergers. Dan digs into the state of fracking, and what it means for the future of American energy, with Bob McNally, president of Rapidan Energy Group.

The election is only eight days away, and it’s not just the candidates whose futures are on the line. Political pollsters, four years after wrongly predicting a Hillary Clinton presidency, are viewing it as their own judgment day. Axios Re:Cap digs into the polls, and what pollsters have changed since 2016, with former FiveThirtyEight writer and current CNN politics analyst Harry Enten.

President Trump’s campaign says it just had its best-ever fundraising day, securing $26 million in the hours around last night’s debate. This just adds to what was already a record-shattering election season, in terms of money raised and money spent. Dan discusses the 2020 fundraising story, including what happens to a candidate's unspent money, with election law expert Ciara Torres-Spelliscy. Plus, Axios financial correspondent Felix Salmon joins to discuss Goldman Sachs.

Short-form video streaming app Quibi announced yesterday that it will cease operations, just six months after a high-profile launch that was backed by $1.75 billion in funding from studios and venture capitalists. Dan digs into what went wrong and what happens next, with REDEF CEO Jason Hirschhorn. Plus, Axios White House reporter Alayna Treene on President Trump’s debate preparation.

Description: The U.S. Justice Department filed a 63-page antitrust lawsuit against Google, related to the tech giant's search and search advertising business. This is just weeks after the House subcommittee on antitrust issued its own scathing report on Google and other Big Tech companies, arguing that they've become digital monopolies. Dan and Rep. David Cicilline (D-R.I.), chair of the subcommittee on antitrust, discuss Google, the DOJ's lawsuit, and Congress' next move.

Plus, Axios political reporter Hans Nichols analyzes a possible Biden campaign strategy on Cabinet appointments.

This week, the Chinese government reported third quarter GDP growth of 4.9%, year-over-year. This comes as the U.S. economy continues to be much weaker, year-over-year, given our relative inability to get COVID-19 under control. Dan examines China's economy, including its increased focus on domestic demand, with CNBC Beijing bureau chief Eunice Yoon.

The presidential race has been dominated by President Trump's handling of the pandemic, but there's been relatively little talk of what Joe Biden would do were he to take office in January. Dan digs into the Biden pandemic plan — including mask mandates, shutdowns, and vaccine distribution — with campaign surrogate Rep. Ami Bera (D-CA).

This weekend, Axios is kicking off Hard Truths, a project examining systemic racism in our country. We’re sharing the first episode of the Hard Truths podcast series.

This will be a year-long series covering a new topic each month - education, housing, technology, and health care. With a bitter election just days away, we start with voting, specifically voter suppression.

Pfizer today said it won't apply for an emergency use authorization for its COVID-19 vaccine until late November, all but guaranteeing that the FDA won't be asked to consider approval until after the election. Dan is joined by Moncef Slaoui, the White House's chief scientific advisor to Operation Warp Speed, the public-private partnership created to get a coronavirus vaccine deployed and developed.